X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

TENX

Closed

Tenax Therapeutics Inc

5.75
-0.01 (-0.17%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 5.76
Day's Range: 5.66 - 6.
Send
When Written:
 
0.384
Tenax Therapeutics Inc. is a biopharmaceutical company that specializes in the development of novel therapeutic products for the treatment of cardiovascular and pulmonary diseases. The company's lead product candidate, levosimendan, is a calcium sensitizer and potassium channel opener that is being developed for the treatment of pulmonary hypertension associated with heart failure and other conditions.

Tenax Therapeutics was founded in 1967 and is headquartered in Morrisville, North Carolina. The company's mission is to develop and commercialize innovative therapies that improve the lives of patients with cardiovascular and pulmonary diseases.

In addition to levosimendan, Tenax Therapeutics is also developing a proprietary formulation of bucindolol, a beta-blocker that is being developed for the treatment of heart failure. The company is also exploring other potential therapeutic targets in the cardiovascular and pulmonary fields.

Tenax Therapeutics is a publicly traded company, and its stock is listed on the NASDAQ exchange under the ticker symbol "TENX".

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X